全球脊椎非固定装置市场类型、应用、地区及预测

脊椎非固定器材市场规模及预测

2024 年脊椎非固定装置市场规模价值为 40.8 亿美元，预计到 2032 年将达到 56.8 亿美元，2026 年至 2032 年的复合年增长率为 4.24%。

脊椎非融合装置是用于治疗各种无需融合脊椎骨节段的脊椎疾病的医疗器材。与将两个或多个脊椎骨融合在一起以固定脊椎的融合手术不同，脊椎非融合装置旨在在治疗退化性椎间盘疾病、脊椎狭窄和其他脊椎疾病的同时，保持脊椎的运动和灵活性。

由于脊椎狭窄和退化性椎间盘疾病等脊椎疾病的发生率不断增加，脊椎非融合装置的市场正在扩大。

脊椎移植用于稳定和激活患者的脊柱，并纠正脊柱失衡。这些装置通常分为脊椎融合装置和脊椎非固定装置。将非固定技术融入脊柱外科手术，使患者能够活动和伸展脊椎，从而改善了治疗效果。

据世界卫生组织称，腰痛影响着从儿童到​​老年人的各个年龄层，是就医的常见原因。腰痛的发生率难以估计，因为成年后它已非常常见，而且很可能反覆发作。预计特异性（全身性）腰痛会在工业国家中影响60%至70%的人口在其一生中的某个阶段。

脊椎非固定器材的全球市场动态

影响全球脊椎非固定装置市场的关键市场动态是：

主要市场驱动因素：

微创手术 (MIS) 的需求日益增长：与标准开放性手术相比，MIS 技术切口较小、失血量更少、恢復时间更快、不适感更少。非固定脊椎固定通常非常适合 MIS 手术，因此对外科医生和患者都具有吸引力。

人口老化日益加剧：世界人口正在老化，老年人越老，就越容易患上退化性椎间盘疾病和脊椎狭窄等脊椎疾病。这些问题会导致疼痛、僵硬和活动能力下降。脊椎非固定装置可以帮助缓解症状，并保持老年人的活动能力。

关注疗效和生活品质：患者报告的疗效和生活品质指标在医疗保健领域日益重要。非固定脊椎装置旨在透过缓解疼痛和功能障碍，以及维持脊椎运动和功能，来维持或改善患者的整体生活品质。

微创方法：许多非融合手术可采用微创技术进行，其优点包括切口小、出血量少、恢復时间短。随着微创手术越来越普及，用于此类手术的脊椎非融合器械的需求也日益增长。

主要挑战

外科医师的训练和应用：非融合脊椎器械通常需要专业的训练和技能才能正确植入。如果外科医师不熟悉手术技术或认为学习难度较高，他们可能会犹豫是否使用这些器械。改善外科医师的教育和培训计画可以解决这个问题，并扩大非融合脊椎器械的应用。

长期临床证据：脊椎非融合装置的临床研究已显示出正面成果，但仍需更多有关其安全性、有效性和耐用性的长期数据。长期临床数据对于获得监管部门批准、确保报销以及增强患者和医疗服务提供者对这些技术长期益处的信心至关重要。

监管挑战：非固定医疗设备的监管流程复杂且漫长，这可能会延迟新设备的开发和商业化。

主要趋势：

老年人口不断增长：随着世界人口老化，越来越多人可能患上脊椎疾病的人。对于无法承受大型手术风险的长者来说，非固定器械或许是适当的选择。

注重疗效和成本效益：全球医疗保健系统日益注重提供基于价值的医疗服务并降低医疗成本。非融合脊椎器械相比标准融合手术，可望改善临床疗效并降低成本，尤其体现在缩短住院时间、降低再手术率以及提高患者长期满意度。

脊椎疾病认知度不断提升：人们对脊椎狭窄症和退化性椎间盘疾病等脊椎疾病的认知度不断提升。这导致越来越多的人寻求此类疾病的治疗，从而推动了对非固定脊椎治疗设备的需求。

更重视运动保留：脊椎融合手术可能会减少患者的活动范围。非固定装置旨在保留脊椎运动，可能改善患者的长期疗效。

目录

第一章：全球脊椎非固定器材市场简介

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章 脊椎非固定器材的全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

5. 全球脊椎非固定装置市场（依应用）

• 概述
• 医院

6. 全球脊椎非固定装置市场（按类型）

• 概述
• 人工全人工椎间盘置换术
• 动态稳定化装置
• 环形修復装置

7. 全球脊椎非固定器材市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

8. 全球脊椎非固定装置市场的竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第九章 公司简介

• Centinel Spine, LLC
• B. Braun Melsungen
• Johnson & Johnson
• Medtronic PLC
• Pioneer Surgical Technologies
• Synthes Holding AG
• Depuy Spine
• Globus Medical Inc.
• NuVasive, Inc.
• Zimmer Biomet

第十章 重大进展

• 产品发布/开发
• 合併与收购
• 业务扩展
• 伙伴关係与合作

第十一章 附录

• 相关调查

Non-fusion Spinal Devices Market Size And Forecast

Non-fusion Spinal Devices Market size was valued at USD 4.08 Billion in 2024 and is projected to reach USD 5.68 Billion by 2032, growing at a CAGR of 4.24% from 2026 to 2032.

Non-fusion spinal devices are medical devices used to treat a variety of spine diseases that do not require vertebral segment fusion. Unlike fusion operations, which join two or more vertebrae together to immobilize the spine, non-fusion devices aim to maintain motion and flexibility in the spine while treating degenerative disc disease, spinal stenosis, and other spinal conditions.

The non-fusion spinal devices market is expanding due to the increasing frequency of spinal illnesses such as spinal stenosis and degenerative disc disease.

Spinal implants are used to stabilize and revitalize patients' spines, as well as to right spinal disproportions. These devices are generically categorized as fusion or non-fusion spinal devices. Integrating non-fusion technologies into spinal surgery has improved outcomes by allowing patients to move and stretch their spines.

According to the WHO, back pain affects everyone, regardless of age, from children to the elderly, and is a common reason for medical visits. It is difficult to estimate the incidence of back pain because it is already extremely common by the time a person reaches adulthood, and the symptoms are likely to repeat throughout time. Non-specific (common) back pain is expected to affect 60% to 70% of people in industrialized countries over their lifespan.

Global Non-fusion Spinal Devices Market Dynamics

The key market dynamics that are shaping the global non-fusion spinal device market include:

Key Market Drivers:

Increasing Demand for Minimally Invasive Surgery (MIS) Treatments: MIS techniques are associated with smaller incisions, less blood loss, faster recovery times, and less discomfort than standard open operations. Non-fusion spinal devices are frequently well-suited for MIS treatments, boosting their appeal to both surgeons and patients.

Expanding Aging Population: The global population is aging, and as people get older, they are more susceptible to developing spine diseases such as degenerative disc degeneration and spinal stenosis. These problems can lead to pain, stiffness, and trouble moving. Non-fusion spinal devices can help relieve symptoms and maintain mobility in older persons.

Focus on Outcomes and Quality of Life: Patient-reported outcomes and quality of life metrics are becoming increasingly important in healthcare. Non-fusion spinal devices are intended not just to relieve pain and dysfunction, but also to maintain or improve patients' overall quality of life by maintaining spinal motion and function.

Minimally Invasive Approaches: Many non-fusion operations can be performed with minimally invasive techniques, which have advantages such as smaller incisions, less blood loss, and faster recovery times. As minimally invasive procedures become increasingly popular, there is a greater demand for non-fusion spinal devices that work with these techniques.

Key Challenges:

Surgeon Training and Adoption: Non-fusion spinal devices frequently necessitate specialized training and skill to properly implant. Surgeons may be hesitant to use these devices if they are unfamiliar with the surgical techniques or see a steep learning curve. Improving surgeon education and training programs can help to address this issue and enable greater utilization of non-fusion spinal devices.

Long-Term Clinical Evidence: While clinical studies on non-fusion spinal devices have provided positive results, more long-term data on their safety, efficacy, and durability are required. Long-term clinical data is critical for obtaining regulatory clearance, securing payment, and instilling patient and healthcare provider confidence in these technologies' long-term advantages.

Regulatory Challenges: The regulation process for non-fusion devices can be complicated and time-consuming. This might cause delays in the development and commercialization of new devices.

Key Trends:

Growing Geriatric Population: As the world's population ages, more people are likely to have spine disorders. Non-fusion devices may be an appropriate choice for older individuals who are unable to fight the risks involved with major surgery.

Focus on Outcomes and Cost-Effectiveness: Healthcare systems around the world are increasingly focused on providing value-based care and reducing healthcare costs. Non-fusion spinal devices have the potential to improve clinical outcomes and cost savings over standard fusion surgeries, particularly in terms of shorter hospital stays, lower rates of revision surgery, and better long-term patient satisfaction.

Growing Awareness of Spinal Disorders: There is a growing awareness of spinal disorders, such as spinal stenosis and disc degeneration. This is leading to more people seeking treatment for these conditions, which is driving up the demand for non-fusion spinal devices.

Increasing Focus on Motion Preservation: Spinal fusion surgery might reduce a patient's range of motion. Non-fusion devices aim to maintain motion in the spine, which can result in better long-term outcomes for patients.

Global Non-fusion Spinal Devices Market Regional Analysis

Here is a more detailed regional analysis of the global non-fusion spinal device market:

North America:

The benefits of non-fusion spinal devices corresponds in North America have seen a quick adoption of modern medical technology, particularly non-fusion spinal devices, because of variables such as high healthcare spending, a robust research and development infrastructure, and a strong demand for new treatment choices. Patients and healthcare providers in the region are increasingly embracing minimally invasive procedures that enable quicker recovery periods and better outcomes.

Government activities and policies in North America have contributed significantly to the introduction of non-fusion spinal devices. Efforts to improve the quality of life for people suffering from spinal problems have resulted in increasing funding for R&D and healthcare infrastructure. Furthermore, regulatory authorities such as the FDA in the United States have simplified the approval procedure for these devices, enabling fast market access and encouraging innovation in the industry.

Overall, a favorable regulatory environment, innovations in technology, and government assistance have pushed North America to the forefront of the spinal non-fusion device market. As the region continues to prioritize healthcare innovation and quality improvement measures, its dominance in this industry is projected to last for the foreseeable future.

Asia Pacific:

The Asia Pacific area offers promising market opportunities for spinal non-fusion devices, due to factors such as rising awareness of healthy living, growth of medical facilities, and a significant increase in elderly people. With an increasing emphasis on preventative healthcare and greater access to medical services throughout the region, people are becoming more aware of the necessity of preserving spinal health. This increased knowledge, combined with a rise in healthcare infrastructure development, presents a favorable climate for the adoption of innovative spinal treatment options, such as non-fusion devices.

Furthermore, the Asia Pacific region is undergoing a large demographic shift, with a substantial increase in aged people. According to the United Nations Economic and Social Commission for Asia and the Pacific demographic statistics sheet from 2016, 12.4% of the region's population was 60 years or older, a proportion that is anticipated to rise even higher by 2050.

This demographic trend highlights the increased demand for innovative solutions to age-related spinal disorders, which is driving the regional non-fusion spinal device market. As Asia Pacific's healthcare systems modernize and focus on meeting the demands of an aging population, the market for spinal non-fusion devices is expected to rise significantly.

Global Non-fusion Spinal Device Market: Segmentation Analysis

The Global Non-fusion Spinal Device Market is Segmented on the basis of Type, Application, And Geography.

Non-fusion Spinal Device Market, By Type

• Artificial Discs Replacement
• Dynamic Stabilization Devices
• Annulus Repair Devices

Based on the Component, the market is bifurcated into Artificial Discs Replacement, Dynamic Stabilization Devices and Annulus Repair Devices. Growing markets in the non-fusion spinal device sector. It's difficult to say for certain which is growing the fastest, but annulus repair devices are a relatively new technology that may be enjoying the fastest growth due to an increased emphasis on motion preservation methodologies.

Non-fusion Spinal Device Market, By Application

• Hospitals
• Ambulatory Surgical Centers

Based on Application, the market is segmented into Hospitals and Ambulatory Surgical Centers. However, Ambulatory Surgical Centers are predicted to increase quicker due to the growing preference for minimally invasive treatments and outpatient care. These operations are less expensive and require shorter recovery times, making ASCs a more appealing alternative for both patients and insurance.

Non-fusion Spinal Device Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Non-fusion Spinal Device Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the largest market share of non-fusion spinal device followed by Europe. Growing demand for effective emergency care and increasing adoption of mobile surgery centers are anticipated to drive the industry during the forecast period.

Key Players

The "Global Non-fusion Spinal Device Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Centinel Spine, LLC, B. Braun Melsungen, Johnson & Johnson, Medtronic PLC, Pioneer Surgical Technologies, Synthes Holding AG, Depuy Spine, Globus Medical Inc., and NuVasive, Inc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Non-fusion Spinal Device Market Recent Developments
• In June 2024, Premia Spine got FDA approval for its Total Posterior Spine (TOPS) facet joint replacement system. The TOPS System previously received the FDA's Breakthrough Designation and has now successfully completed its Premarket Approval (PMA) application. The TOPS(TM) System replaces anatomical elements destroyed during spinal decompression treatment, such as the lamina and facet joint, to relieve pain.
• In November 2022, Spinal Stabilization Technologies Ltd announced that it has begun the LOPAIN2 clinical trial to assess the effectiveness of the PerQdisc Nucleus Replacement Device (NRD). The trial is expected to take place in South America, with 72 patients participating.
• In August 2021, Orthofix US LLC announced the first patient implant in the M6-C Artificial Cervical Disc 2-Level Investigation Device Exemption (IDE) Study. The FDA authorized the M6-C artificial cervical disc in 2019 for single-level implantation from C3 to C7 as an alternative to cervical fusion.
• In April 2021, NuVasive Inc received 510k approval from the US FDA for the use of Simplify Disc, a two-level cervical complete disc replacement.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NON-FUSION SPINAL DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NON-FUSION SPINAL DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NON-FUSION SPINAL DEVICES MARKET, BY APPLICATION

• 5.1 Overview
• 5.2 Hospitals

6 GLOBAL NON-FUSION SPINAL DEVICES MARKET, BY TYPE

• 6.1 Overview
• 6.2 Artificial Discs Replacement
• 6.3 Dynamic Stabilization Devices
• 6.4 Annulus Repair Devices

7 GLOBAL NON-FUSION SPINAL DEVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL NON-FUSION SPINAL DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Centinel Spine, LLC
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 B. Braun Melsungen
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Johnson & Johnson
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Medtronic PLC
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Pioneer Surgical Technologies
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Synthes Holding AG
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Depuy Spine
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Globus Medical Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 NuVasive, Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Zimmer Biomet
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research